1/ Question for #MMsm hive mind 🙏

For patients with functional high-risk myeloma (e.g., relapse ≤18 mo of 1st-line Tx), any good summary of data for functional high-risk vs high-risk FISH vs both?

Summarizing what I found so far, but I know I must be missing a few studies! Image
2/ In KarMMa-2 Cohort A from #ASH22 by @szusmani @DrKrinaPatel et al, 37 patients with #MMsm enrolled in early ide-cel trial for functional high-risk.

Of n=22 with evaluable FISH (I wish it were a little higher), 45% didn't have any high-risk features.

ashpublications.org/blood/article/… Image
3/ In #ASH21 RWE #MMsm database analysis by @kansagraMD et al, 1719 pts analyzed inc. hypodiploid as high-risk 🐠

Thanks Ankit for this awesome work! Am I analyzing abstract correctly to say that 73% of functional high-risk pts had standard FISH? 🤯

ashpublications.org/blood/article/… Image
4/ In @BloodCancerJnl analysis of @theMMRF CoMMpass data set for "functional super-high-risk" #MMsm patients: relapse ≤12 mo of Tx initiation) *or* ≤MR to induction...

Not much black in bottom half of heat map.
nature.com/articles/s4140…

Any other studies I'm missing? Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Rahul Banerjee, MD, FACP

Rahul Banerjee, MD, FACP Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @RahulBanerjeeMD

Apr 3, 2020
(1/20) Just finished leading a conference about #COVID19 and hematology. >50% of my citations were preprints, so that got me thinking: why write my own preprint when I can just do a tweetorial? So here goes: 🎺🥁[fanfare] COVID-19 for the HEME CONSULT fellow or attending. Image
(2/20) This is a saga about #COVID19 and non-malignant hematology* in three chapters:
1) COVID-19 and lymphocytes
2) COVID-19 and platelets
3) COVID-19 and RBCs

* Or should I say, “classical hematology.” Image
(3/20) For #COVID19 and lymphocytes: Lymphopenia is bad, and lymphocyte % (on diff) starting <20% ➡️5% over time is even worse. Mehh methods but good commentary, spelled out in this excellent tweetorial by @Leo_ReapDO
Read 21 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(